Handheld Mole Imaging System Demonstrates Noninvasive Detection of Melanoma Activity
The molecular Skin Fluorescence Imaging System noninvasively identifies and assesses activity associated with melanoma development.
Read MorePosted by Andy Lundin | Jan 16, 2024 | Melanoma, Molecular Diagnostics |
The molecular Skin Fluorescence Imaging System noninvasively identifies and assesses activity associated with melanoma development.
Read MorePosted by Andy Lundin | Jan 15, 2024 | Company News |
Veracyte will acquire C2i Genomics, a MRD detection company, adding whole-genome MRD capabilities to its diagnostics platform.
Read MorePosted by Chris Wolski | Jan 12, 2024 | Digital Pathology |
By examining the UK’s technology-centric strategy and response, nations can right-size the practice of pathology and prepare for the future.
Read MorePosted by Andy Lundin | Jan 9, 2024 | Cancer, Research |
PanGIA Biotech is preparing to launch new clinical studies in multi-cancer early detection using the PanGIA Liquid Biopsy Platform.
Read MorePosted by Andy Lundin | Jan 9, 2024 | Diagnostic Technologies |
Picodya, the creator of a hybrid IVD solution for multiplexed POC testing, announced the deployment of its B-Matrix technology in NIH labs.
Read More